Cresco Labs Stock Forecast, Price & News

Cresco Labs (OTCMKTS:CRLBF) Frequently Asked Questions

Is Cresco Labs a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cresco Labs stock.
View analyst ratings for Cresco Labs or view top-rated stocks.

How has Cresco Labs' stock price been impacted by COVID-19?

Cresco Labs' stock was trading at $3.34 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CRLBF stock has increased by 144.6% and is now trading at $8.1703.
View which stocks have been most impacted by COVID-19.

Are investors shorting Cresco Labs?

Cresco Labs saw a increase in short interest in the month of October. As of October 29th, there was short interest totaling 441,800 shares, an increase of 22.1% from the October 14th total of 361,900 shares. Based on an average trading volume of 1,114,600 shares, the days-to-cover ratio is presently 0.4 days.
View Cresco Labs' Short Interest.

What price target have analysts set for CRLBF?

6 equities research analysts have issued twelve-month target prices for Cresco Labs' shares. Their forecasts range from $19.00 to $36.00. On average, they anticipate Cresco Labs' share price to reach $25.50 in the next year. This suggests a possible upside of 212.1% from the stock's current price.
View analysts' price targets for Cresco Labs or view top-rated stocks among Wall Street analysts.

Who are Cresco Labs' key executives?

Cresco Labs' management team includes the following people:

• Mr. Charles Bachtell, Co-Founder, CEO & Director (Age 42, Pay $537.5k)
• Mr. Dennis M. Olis, Chief Financial Officer (Age 58, Pay $202.12k)
• Mr. Thomas J. Manning, Exec. Chairman (Age 64)
• Mr. Robert M. Sampson, Co-Founder & Director (Age 46)
• Mr. Ty Gent, Chief Operating Officer (Age 62)
• Ms. Brenna Albert CPA, Sr. VP and Controller of Accounting, Treasury & Tax
• Mr. Mo Dastagir, Chief Information Officer (Age 44)
• Jake Graves, Mang. of Investor Relations
• Mr. John Schetz, Gen. Counsel (Age 44)
• Ms. Impola Kelli, VP of Compliance

Who are some of Cresco Labs' key competitors?

Some companies that are related to Cresco Labs include Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF), Chalice Brands (GLDFF) and Charlotte's Web (CWBHF).
View all of CRLBF's competitors.

What is Cresco Labs' stock symbol?

Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."

How do I buy shares of Cresco Labs?

Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cresco Labs' stock price today?

One share of CRLBF stock can currently be purchased for approximately $8.17.

How many employees does Cresco Labs have?

Cresco Labs employs 2,700 workers across the globe.

What is Cresco Labs' official website?

The official website for Cresco Labs is www.crescolabs.com.

Where are Cresco Labs' headquarters?

Cresco Labs is headquartered at 400 West Erie Street, Chicago, IL 60654.